Nigeria's leading finance and market intelligence news report.

India’s Glenmark Pharma cuts price of COVID-19 drug by 27% to N380 per tablet

India’s leading drug manufacturer, Glenmark Pharmaceuticals on Monday said it has cut price of its antiviral drug Favipiravir, under the brand name FabiFlu, for the treatment of patients with mild to moderate COVID-19, by 27 per cent to Rs 75 or about N380 per tablet. Glenmark Pharmaceuticals had launched FabiFlu last month at a price…

Join the BusinessDay Inner Circle to read exclusives and gain insights for N1000/month

Get real time updates directly on you device, subscribe now.

Comments are closed.